Wedbush Cuts Price Target on Surface Oncology to $3 From $12, Citing New Clinical Data, Updated Pipeline Focus; Outperform Rating Kept
Wedbush Cuts Price Target on Surface Oncology to $3 From $12, Citing New Clinical Data, Updated Pipeline Focus; Outperform Rating Kept
Wedbush以新的臨床數據和最新的管道焦點爲由將表面腫瘤學的目標股價從12美元下調至3美元；維持跑贏大盤評級
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊